Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

Exudative Macular Degeneration Clinical Trial

Official title:
A Multicenter, Randomized, Sham-controlled, Repeat-dose Study to Assess the Safety, Tolerability, Serum Pharmacokinetics, and Efficacy of Intravitreal LFG316 in Patients With Neovascular Age-related Macular Degeneration

Status Completed

Clinical Trial Summary

This study will assess the safety and efficacy of LFG316 in patients with age related macular degeneration.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Exudative Macular Degeneration
Macular Degeneration
Neovascular Age-elated Macular Degeneration (Wet AMD)
Wet Macular Degeneration

Clinical Trial Details

NCT number	NCT01535950
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 2
Start date	February 2012
Completion date	July 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01835067` - Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD	Phase 2/Phase 3
Completed	`NCT01674569` - Pilot Study of X-82 in Patients With Wet AMD	Phase 1/Phase 2
Recruiting	`NCT04504123` - MMP-9 Inhibition for Recalcitrant Wet AMD	Phase 2
Completed	`NCT01473251` - Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration	N/A
Recruiting	`NCT05093374` - Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting	Phase 4
Completed	`NCT01617148` - Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept	Phase 4
Completed	`NCT02287298` - Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment	N/A
Active, not recruiting	`NCT03803631` - CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)